(Q45154446)

10 December 2017

Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate (English)

1 reference

10 December 2017

van Vliet HA

1

1 reference

10 December 2017

Winkel TA

2

1 reference

10 December 2017

Noort I

3

1 reference

10 December 2017

Rosing J

4

1 reference

10 December 2017

Rosendaal FR

5

1 reference

10 December 2017

1 November 2004

1 reference

Journal of Thrombosis and Haemostasis

10 December 2017

1 reference

10 December 2017

2

1 reference

10 December 2017

11

1 reference

10 December 2017

2060-2062

1 reference

Oral contraceptives and the risk of venous thrombosis

10 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00983.X

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00983.X

Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00983.X

Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00983.X

10.1111/J.1538-7836.2004.00983.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference